Envoy Medical Inc. Cash Flow Conversion Efficiency

Latest as of June 2026: -1.652x

Envoy Medical Inc. cash flow conversion efficiency. Based on the latest financial reports, Envoy Medical Inc. (COCH) has a cash flow conversion efficiency ratio of -1.652x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-5.46 Million) by net assets ($3.30 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Envoy Medical Inc. (2021–2025)

Cash flow conversion efficiency of Envoy Medical Inc. from 2021 to 2025. This chart illustrates how Envoy Medical Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View Envoy Medical Inc. stock price for real-time trading data and today's change.

Envoy Medical Inc. Cash Flow Conversion Ratio Explained

Envoy Medical Inc. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Envoy Medical Inc. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Envoy Medical Inc. ranked by their cash flow conversion efficiency. Also see Envoy Medical Inc. market cap and net worth for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Xplus SA
WAR:XPL
0.059x
Solutions 30 SE
PA:S30
-0.281x
Barratt Redrow plc
LSE:BTRW
-0.043x
Dutaland Bhd
KLSE:3948
-0.019x
Wittchen SA
WAR:WTN
0.113x
Uniflex Technology Inc
TW:3321
-0.087x
Decibel Cannabis Company Inc
V:DB
0.028x
E3 LITHIUM LTD
F:OW3
-0.025x

Annual Cash Flow Conversion Efficiency for Envoy Medical Inc. (2021–2025)

The table below shows the annual cash flow conversion efficiency of Envoy Medical Inc. from 2021 to 2025. Review how much free cash does Envoy Medical Inc. generate to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $-11.77 Million $-18.20 Million 1.547x +62.37%
2024-12-31 $-18.84 Million $-17.95 Million 0.953x -90.10%
2023-12-31 $-1.78 Million $-17.09 Million 9.623x +3855.89%
2022-12-31 $-36.20 Million $-8.80 Million 0.243x +57.69%
2021-12-31 $-44.96 Million $-6.94 Million 0.154x --

About Envoy Medical Inc.

NASDAQ:COCH USA Medical Devices
Market Cap
$511.03 Million
Market Cap Rank
#21338 Global
#4792 in USA
Share Price
$6.62
Change (1 day)
-0.45%
52-Week Range
$0.39 - $6.66
All Time High
$10.50
About

Envoy Medical, Inc., a hearing health company, provides medical technologies across the hearing loss spectrum. The company's medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire. It offers personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseoin… Read more